Free consultancy · EU MDR check-up · 60 minutes

A free hour with a former Notified Body reviewer.

Book a free 60-minute EU MDR check-up. Bring your device and your questions; we map your gaps, your fastest compliant route and where evidence is missing, with no obligation.

Free 60 minutesEU MDR check-upGap analysisNo obligationFormer NB reviewer
Eclevar MedTech Platinum Award xShare EUCROF Amsterdam Platinum Award 2026

Eclevar MedTech and Milo took the Platinum Award at xShare & EUCROF.

Top prize in the xShare x European CRO Federation "EHDS & Clinical Research" Open Call, awarded to Eclevar MedTech and its Milo Health platform, presented at the EUCROF 2026 conference in Amsterdam.

Co-funded by the European Union

Horizon Europe · Grant Agreement No. 101136734 · Amsterdam, 2 Feb 2026

Social proof

Trusted by MedTech manufacturers.

Leading device manufacturers choose Eclevar for clinical evidence and real world evidence. Read all client success stories.

TERUMOMerilNIHON KOHDENVYGONColoplastSHOFUASAHI INTECCRegenLabTERUMOMerilNIHON KOHDENVYGONColoplastSHOFUASAHI INTECCRegenLab
Dr Mark Da Costa, COO Eclevar MedTech, former TUV SUD Notified Body reviewer
Dr Mark Da CostaCOO · Former Notified Body reviewer · Senior Consultant SurgeonFormer reviewer atTUV SUD
Regulatory leadership

One hour that saves you months.

Your free session is run by senior people who assessed technical files from inside Notified Bodies. Dr Mark Da Costa, COO and former TÜV SÜD reviewer, and the team read your situation the way a reviewer will, and tell you plainly what stands between you and CE marking.

Ex NBFormer TÜV SÜD reviewer
7Countries with in-house CRAs (UK, DE, FR, SE)
Chapter VIEU MDR Articles 62-82
Former NB reviewerEU MDR check-upISO 14155:2026
LinkedIn
Compliant withEU MDR 2017/745ISO 14155:2026GCPISO 13485GDPR
Why a check-up

Find the gaps before your Notified Body does.

Most CE-marking delays come from problems that were visible early: weak equivalence, thin PMCF, an incomplete CER or a mis-classified device. A focused hour with a former reviewer surfaces them while they are still cheap to fix.

You leave the call with a clear read of your risk class, your evidence gaps and the fastest compliant route, whether or not you work with us.

Clinical data analysis and biometrics for medical devices
What we review

What your free hour covers.

A structured, senior review of the essentials, tailored to your device.

01
Class

Classification & strategy

Confirming your risk class and conformity-assessment route.

02
Gaps

Evidence gap analysis

Where CER, PMCF and clinical data fall short.

03
Route

Fastest compliant route

A prioritized path to Notified Body ready evidence.

In-house CRAs

We do not outsource monitoring

Eclevar deploys in-house Clinical Research Associates in the United Kingdom, Germany, France and Sweden, ensuring smooth study initiation, ethics-committee submissions (for example CPP in France) and high-quality clinical data collection.

How it works

Simple, senior, no obligation.

01

Book a slot

Pick a 60-minute slot; tell us your device and indication.

02

The check-up

A structured review with a former Notified Body reviewer.

03

Your action list

A clear, prioritized list of what to do next.

What you take away
01

Class confirmation

Certainty on your risk class and pathway.

02

Gap map

A clear map of your evidence gaps.

03

Priorities

What to fix first, and why.

04

Timeline view

A realistic view of your route to CE marking.

05

Cost awareness

Where budget will actually be needed.

06

No obligation

Actionable advice whether or not you engage us.

Our methodology

A simple three-step check-up.

Data quality means completeness, consistency and accuracy across all investigational sites.

1

Book

Choose a free 60-minute slot online.

2

Prepare

Share your device, indication and current documents.

3

Check-up

A structured senior review of your situation.

4

Action list

A prioritized list of next steps.

5

Follow-up

Optional proposal for the fastest compliant route.

Selected experience

Programs we have delivered.

RegenLab · Advanced wound care

Registry-based RWE-PMCF for wound care

Advanced wound care device · CE mark renewal

RegenLab needed PMCF data to renew its CE marking without disrupting clinical workflows. Eclevar designed a targeted RWE-PMCF registry study on the MILO EDC platform capturing wound-healing trajectories and adverse-event tracking.

160patients · 14 sites
5EU countries
MDRChapter VI
RWE registryMILO EDCWound care
Vascular patch · Class III

Multicentre study on a Class III vascular patch

Knitted polyester vascular prosthesis · EU MDR Chapter VI

Multicentre study with retrospective and prospective record data from French university hospitals (CHU Valenciennes, Nantes, Brest), covering carotid and femoral locations up to 3 years post-op and meeting EU MDR requirements for CE certification.

250-300patients · 3-8 sites
3 yrsfollow-up
≥100per location
Class IIICHU networkChapter VI
Regulatory framework

Compliant in EU, France, Germany and the UK.

EU
EU MDR

EU MDR 2017/745

  • Clinical evidence under Chapter VI (Articles 62-82)
  • PMCF plan mandatory for Class IIb and III
  • Clinical Evaluation Report and ISO 14155:2026
  • Notified Body review and competent authority reporting
FR
ANSM

France

  • EU MDR plus national requirements
  • Ethics committee (CPP) approval
  • Data collection across the French hospital network
  • Annual safety reports, French documentation
DE
BfArM

Germany

  • EU MDR plus national requirements
  • Protocols filed with BfArM
  • Ethics committee approval mandatory
  • Quarterly safety reports, German documentation
UK
MHRA

United Kingdom

  • UK MDR, aligned with the EU MDR
  • Plan for Class IIb and III
  • Research Ethics Committee (REC) approval
  • NHS hospital data, annual reports to the MHRA
Official content

Our content, signed Eclevar.

Whitepapers, client testimonials and publications produced by our teams and partners (BSI, TÜV SÜD, RegenLab).

Whitepaper by BSI and Eclevar on the EU MDR
Whitepaper · BSI × Eclevar

A BSI and Eclevar whitepaper on the EU MDR.

Written with Notified Body BSI: a practical reading of the clinical evidence expectations under EU MDR 2017/745, relevant to any clinical program.

PMCF Studies · Regenerative Medicine · 5 EU Countries

A client's live testimonial on Eclevar's capability to run complex trials.

Eclevar manages RegenLab's PMCF program on chronic wound devices: a randomized study of 160 patients across 14 sites in 5 EU countries, covering both diabetic foot ulcer (DFU) and venous leg ulcer (VLU) indications. The partnership combines Eclevar's ISO 14155 clinical expertise with the Milo Studio platform to deliver post-market clinical follow-up evidence that supports both Notified Body scrutiny and reimbursement endpoints.

« Eclevar, with its tailor-made approach and advanced Milo Studio platform, represents a major strategic asset. »
Antoine Turzi, CEO, RegenLab
160patients · 14 sites
5EU countries
RegenLab video testimonial on the PMCF programme managed by Eclevar
FAQ

The free consultancy, answered.

Is it really free?

Yes. The 60-minute EU MDR check-up is free and carries no obligation.

Who runs the session?

Senior people who assessed technical files from inside Notified Bodies, including a former TÜV SÜD reviewer.

What should I prepare?

Your device, its intended purpose and any existing documents (draft CER, classification, test reports).

What do I get out of it?

A clear read of your risk class, your evidence gaps and the fastest compliant route, plus a prioritized action list.

Am I committed to anything?

No. The advice is actionable whether or not you decide to work with Eclevar.

Guaranteed response within 24 hours

Book your free EU MDR check-up.

Tell us your device and indication; a former Notified Body reviewer will map your fastest compliant route in 60 minutes, no obligation.

Book a free call

Reforming Clinical Evaluation of Medical Devices in Europe